$6.33
7.93% today
NYSE, Jul 29, 09:20 pm CET

Fortrea Stock price

$6.87
+1.93 39.07% 1M
-10.28 59.94% 6M
-11.78 63.16% YTD
-20.42 74.83% 1Y
-23.23 77.18% 3Y
-23.23 77.18% 5Y
-23.23 77.18% 10Y
-23.23 77.18% 20Y
NYSE, Closing price Mon, Jul 28 2025
+0.07 1.03%

Key metrics

Basic
Market capitalization
$621.7m
Enterprise Value
$1.7b
Net debt
$1.1b
Cash
$101.6m
Shares outstanding
90.5m
Valuation (TTM | estimate)
P/E
negative | 14.3
P/S
0.2 | 0.2
EV/Sales
0.7 | 0.7
EV/FCF
11.9
P/B
0.7
Financial Health
Equity Ratio
38.1%
Return on Equity
-24.1%
ROCE
-4.8%
ROIC
-4.1%
Debt/Equity
1.4
Financials (TTM | estimate)
Revenue
$2.7b | $2.6b
EBITDA
$-19.6m | $177.1m
EBIT
$-102.5m | $140.8m
Net Income
$-790.4m | $43.4m
Free Cash Flow
$145.1m
Growth (TTM | estimate)
Revenue
-10.7% | -4.8%
EBITDA
-116.1% | 768.3%
EBIT
-492.7% | 225.9%
Net Income
-548.9% | 113.2%
Free Cash Flow
38.2%
Margin (TTM | estimate)
Gross
20.2%
EBITDA
-0.7% | 6.9%
EBIT
-3.8%
Net
-29.4% | 1.7%
Free Cash Flow
5.4%
More
EPS
$-8.8
FCF per Share
$1.6
Short interest
24.1%
Employees
16k
Rev per Employee
$170.0k
Show more

Is Fortrea a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Fortrea Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Fortrea forecast:

11x Hold
69%
5x Sell
31%

Analyst Opinions

16 Analysts have issued a Fortrea forecast:

Hold
69%
Sell
31%

Financial data from Fortrea

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,686 2,686
11% 11%
100%
- Direct Costs 2,143 2,143
15% 15%
80%
543 543
8% 8%
20%
- Selling and Administrative Expenses 562 562
49% 49%
21%
- Research and Development Expense - -
-
-
-20 -20
116% 116%
-1%
- Depreciation and Amortization 83 83
13% 13%
3%
EBIT (Operating Income) EBIT -103 -103
493% 493%
-4%
Net Profit -790 -790
549% 549%
-29%

In millions USD.

Don't miss a Thing! We will send you all news about Fortrea directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortrea Stock News

Neutral
PRNewsWire
about 5 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 o...
Neutral
GlobeNewsWire
about 21 hours ago
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Fortrea Holdings (FTRE) To Contact Them To Discuss Their Options
Neutral
GlobeNewsWire
one day ago
Investors can contact the law firm at no cost to learn more about recovering their losses
More Fortrea News

Company Profile

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Head office United States
CEO Peter Neupert
Employees 16,000
Founded 2023
Website www.fortrea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today